The World Health Organization is set to recommend weight-loss drugs like Wegovy and Zepbound for treating obesity in adults, marking its first official backing of such medications and signaling a major shift in global health policy.
-The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first time, a memo reviewed by Reuters on Thursday shows, marking a shift in its approach to treating the global health problem.
The UN agency also called for strategies to improve access to the treatment in low- and middle-income countries.
More than a billion people now have obesity worldwide, according to the WHO, and around 70% of them live in low and middle-income countries, the World Bank estimates.
The wildly popular obesity drugs - Wegovy developed by Novo Nordisk and Zepbound by Eli Lilly - are known as GLP-1 receptor agonists, which mimic the activity of a hormone that slows digestion and helps people feel full for longer. In clinical trials, people lost 15% to 20% of their body weight, depending on the drug.
The drugs have been launched in the United States and other high-income countries like Germany and Britain.
But they can cost over $1,000 a month, and studies suggest people may have to take the drugs for the rest of their lives to keep the weight off.
The WHO, Eli Lilly and Novo Nordisk were not immediately available for comment.
The WHO's conditional recommendation will be officially released in August, as part of new guidelines on treating obesity. It is also working on separate guidelines for children and adolescents.
Separately, WHO experts will also meet next week to decide whether to include the GLP-1 drugs in the agency's essential medicines list - both to treat obesity and type 2 diabetes.
The WHO's essential medicines list is a catalogue of the drugs that should be available in all functioning health systems, and it can help make drugs more widely available in poorer countries, as experts say happened in 2002 when HIV drugs were included.
In 2023, the experts decided against adding obesity drugs to the list, with WHO saying more evidence was needed on their long-term clinical benefit.
However, in the new memo recommending their use as a treatment, the agency says it supports including them on the list this time round.
Still, the WHO also raises concerns over the cost of the drugs and calls for longer-term studies on cost-effectiveness "across all settings, including LMICs" (low- and middle-income countries).
"The same mechanisms that are used in large-scale medicine access programmes may need to be adopted," to improve access, the WHO adds, such as tiered pricing or pooled procurement.
But it also notes that the active ingredient in one of the newer drugs, semaglutide - used in Novo's Wegovy - comes off patent in some markets next year.
Several companies are planning to launch cheaper generic versions of the drugs then. Liraglutide, the active ingredient in the older generation of drugs, is already available as a lower-cost generic drug, with products approved in the U.S. and Europe, the memo adds.
A tragic plane crash early Thursday morning shook a quiet residential neighborhood in San Diego, California. According to officials, there are two dead, eight injured.
Adidas and Puma are expected to raise prices in the U.S. after Nike increased footwear costs, as rising import tariffs push up expenses across the sportswear industry.
Israeli Prime Minister Benjamin Netanyahu harshly criticized UK’s Starmer, France’s Macron, and Canada’s Carney for urging a halt to Israel’s military action in Gaza, accusing them of siding with Hamas and undermining justice.
The second meeting of customs leaders from Central Asia and China was held in Almaty, focusing on digitalization, AI integration, border crossing agreements, and expanding cooperation to strengthen regional trade and logistics.
Azerbaijan’s Minister of Economy Mikayil Jabbarov has been appointed Chairman of the Board of Governors of the Islamic Development Bank Group, with the 2026 Annual Meeting set to take place in Azerbaijan.
Northern France sees major farmer protests as key agricultural reforms face parliamentary review, sparking road blockades and rising tensions.
The Trump administration is moving toward lifting sanctions on Syria, but officials caution that coordinating between government agencies means the process will take longer than initially expected.
The 7th Ethnosport Culture Festival kicked off in Istanbul with Azerbaijan’s 100-member team and famed Karabakh horses drawing major attention.
Iran’s foreign minister Abbas Araqchi declared that the United States would bear legal responsibility if Israel launches an attack on Iranian nuclear facilities, amid reports of potential Israeli military action and ongoing nuclear negotiations in Rome.
A rare naval misstep has shaken North Korea’s tightly choreographed military image, prompting an urgent internal probe and public scolding from Kim Jong Un.
Tensions flare in the India-France Rafale deal as France refuses to share the fighter jet’s source code, limiting India’s ability to integrate indigenous weapons and reducing its combat autonomy.
France has rejected India’s request to share source codes needed to integrate indigenous weapons into Rafale fighter jets. Despite repeated appeals, French manufacturer Dassault Aviation has refused to compromise on the issue
Anton Kobyakov, adviser to Russian President Vladimir Putin, claimed at the St. Petersburg International Legal Forum that the USSR’s dissolution was legally invalid and that the Soviet Union still exists under constitutional law, framing the Ukraine war as an “internal process.”
AnewZ and Kazakhstan’s Jibek Joly/Silk Way TV channel co-hosted a special AnewZ Talks in Astana at Maqsut Narikbayev University (MNU), uniting global experts and young leaders at Silk Road Media Group’s journalism school to explore the growing intersection of media and diplomacy.
The Tehran Dialogue Forum 2025, scheduled for May 18–19, will host 200 international guests, including 40 current and former European officials.
G7 finance leaders meeting in Canada pledged to tackle global imbalances and suggested tougher sanctions on Russia, while also taking aim at unfair economic practices widely attributed to China.
Researchers have developed a new testing method that could diagnose brain tumors within hours, potentially allowing treatment to begin during surgery.
Southeast Asia is witnessing a renewed surge in COVID-19 infections, with Singapore, Hong Kong, China, and Thailand all reporting sharp increases, raising concerns about a possible new wave of the virus across the region.
In January 2025, the CIA made headlines by revising its position on the origins of COVID-19, now favoring the laboratory leak theory over natural origins.
Matcha and coffee have both surged in popularity as go-to beverages for energy and potential health benefits. While coffee has long dominated the morning routine of many people worldwide, matcha-a powdered form of specially grown green tea-has emerged as a compelling alternative.
Northern France sees major farmer protests as key agricultural reforms face parliamentary review, sparking road blockades and rising tensions.
The Trump administration is moving toward lifting sanctions on Syria, but officials caution that coordinating between government agencies means the process will take longer than initially expected.
The 7th Ethnosport Culture Festival kicked off in Istanbul with Azerbaijan’s 100-member team and famed Karabakh horses drawing major attention.
Iran’s foreign minister Abbas Araqchi declared that the United States would bear legal responsibility if Israel launches an attack on Iranian nuclear facilities, amid reports of potential Israeli military action and ongoing nuclear negotiations in Rome.
A rare naval misstep has shaken North Korea’s tightly choreographed military image, prompting an urgent internal probe and public scolding from Kim Jong Un.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment